- A penetrating injury to the left eye results in the release of intraocular proteins into the circulation. Weeks later, the patient develops a T-cell mediated autoimmune attack against retinal antigens in both the injured left eye and the uninjured right eye (sympathetic ophthalmia). This phenomenon occurs because:
Answer: The eye is an immune-privileged site, and trauma breaks the sequestration of tissue-specific antigens.
The eye, brain, and testes are immune-privileged sites, meaning they are anatomically and physiologically separated from the systemic immune system. Lymphocytes do not normally circulate through them, and their unique antigens are 'sequestered'. Central tolerance to these sequestered antigens may be incomplete. When physical trauma breaches this barrier, the sequestered antigens are released, drain to regional lymph nodes, and are presented to T cells, initiating a primary immune response. Once activated, these effector T cells can circulate systemically and cross the blood-retinal barrier in both eyes to cause widespread damage.
- Which of the following scenarios best depicts a failure of peripheral tolerance, rather than central tolerance?
Answer: An individual with a FOXP3 mutation lacks functional regulatory T cells, leading to systemic autoimmunity.
When you encounter questions about immune tolerance, focus on the key distinction: central tolerance occurs in primary lymphoid organs (thymus and bone marrow) during lymphocyte development, while peripheral tolerance operates in secondary lymphoid organs and tissues after mature lymphocytes have already been released.
Answer A correctly represents peripheral tolerance failure. FOXP3 is the master transcription factor for regulatory T cells (Tregs), which are mature T cells that suppress immune responses in peripheral tissues. When FOXP3 is mutated, Tregs cannot function properly, leading to uncontrolled immune activation against self-antigens in the periphery. This causes IPEX syndrome (immunodysregulation, polyendocrinopathy, enteropathy, X-linked).
Answer B describes central B cell tolerance - this high-avidity self-reactive B cell is eliminated in the bone marrow (primary lymphoid organ) before it can mature and enter circulation. Answer C represents central T cell tolerance failure - the AIRE gene controls presentation of tissue-specific antigens in the thymus, so defects allow self-reactive T cells to escape thymic deletion and mature inappropriately. Answer D describes normal positive selection in the thymus, where T cells must recognize self-MHC to survive - this is a central tolerance mechanism working correctly.
Remember this pattern: if the question involves mature, functional immune cells causing problems in tissues or secondary lymphoid organs, think peripheral tolerance. If it involves developing lymphocytes in thymus or bone marrow, think central tolerance. FOXP3 and Tregs are classic peripheral tolerance players.
- One hypothesis for the strong association of HLA-B27 with ankylosing spondylitis suggests that the HLA-B27 heavy chain misfolds within the endoplasmic reticulum (ER). How would this intracellular event most plausibly lead to the characteristic inflammation?
Answer: The accumulation of misfolded protein induces the unfolded protein response (UPR), an ER stress pathway that promotes IL-23 production.
When you encounter questions linking specific HLA alleles to autoimmune diseases, think about the molecular mechanisms that could connect intracellular protein handling to inflammatory responses. HLA-B27's association with ankylosing spondylitis involves more than just antigen presentation.
The HLA-B27 heavy chain is prone to misfolding in the endoplasmic reticulum, where it forms disulfide-bonded dimers and aggregates. This triggers the unfolded protein response (UPR), a cellular stress pathway that attempts to restore ER homeostasis. Crucially, UPR activation upregulates inflammatory cytokines, particularly IL-23, which drives the Th17 immune response characteristic of ankylosing spondylitis. This creates a direct link between intracellular protein misfolding and the specific inflammatory pattern seen in this disease.
Looking at the incorrect options: Choice A misunderstands the location—misfolded proteins stuck in the ER aren't available for presentation by other HLA molecules. Choice B incorrectly assumes that reduced surface expression would primarily trigger NK cells; while HLA-B27 surface levels may decrease, this isn't the main inflammatory mechanism. Choice C focuses on T cell selection in the thymus, but ankylosing spondylitis develops in adults with already-selected T cell repertoires, making this mechanism implausible for disease pathogenesis.
Remember that HLA associations with autoimmune diseases often involve gain-of-function mechanisms (like aberrant protein folding triggering stress responses) rather than simple loss-of-function scenarios. The UPR-IL-23-Th17 pathway represents a key mechanistic bridge between molecular events and tissue inflammation.
- Systemic lupus erythematosus (SLE) has a striking female predominance. Which of the following is considered a primary contributor to this sex bias in autoimmunity?
Answer: Estrogen enhances B cell activation and antibody production, while androgens are generally immunosuppressive.
Sex hormones are known to have significant immunomodulatory effects. Estrogen, the predominant female sex hormone, has been shown to promote B-cell maturation, survival, and class switching, leading to enhanced antibody responses. It can also influence T-cell differentiation. Conversely, androgens tend to have immunosuppressive effects. This hormonal milieu is thought to be a major factor contributing to the increased susceptibility of females to antibody-mediated autoimmune diseases like SLE.
- A patient develops myocarditis weeks after a Streptococcus pyogenes infection. The pathogenesis involves antibodies generated against the streptococcal M protein that are found to cross-react with cardiac myosin. This mechanism of triggering autoimmunity is best described as:
Answer: Molecular mimicry, where a foreign antigen shares structural similarity with a self-antigen.
Molecular mimicry is a well-established mechanism for triggering autoimmunity, where the immune response directed against a pathogen-derived antigen inadvertently targets a structurally similar host (self) antigen. The classic example is acute rheumatic fever following streptococcal infection, where antibodies against the bacterial M protein cross-react with proteins in the heart muscle (like cardiac myosin) and heart valves, leading to carditis.
- A 35-year-old woman with dermatomyositis has high levels of autoantibodies to Jo-1 (histidyl-tRNA synthetase) and carries the HLA-DRB1*0301 allele. A muscle biopsy reveals perimysial inflammation dominated by CD4+ T cells. Which statement provides the most accurate pathophysiological link between these findings?
Answer: The HLA-DRB1*0301 allele presents a Jo-1 peptide to autoreactive CD4+ T cells, which then help B cells and orchestrate muscle inflammation.
When you encounter questions linking HLA alleles, autoantibodies, and tissue inflammation, think about the coordinated immune response where HLA molecules present antigens to T cells, which then orchestrate both cellular and humoral immunity.
In dermatomyositis with anti-Jo-1 antibodies, the pathophysiology follows a classic autoimmune cascade. The HLA-DRB1*0301 allele is a class II MHC molecule expressed on antigen-presenting cells. This particular allele has a binding groove that effectively presents peptides derived from the Jo-1 protein (histidyl-tRNA synthetase) to CD4+ T cells. Once these T cells recognize the Jo-1 peptide as "foreign," they become activated and provide help to B cells for antibody production while simultaneously recruiting inflammatory cells to muscle tissue, explaining both the high anti-Jo-1 antibody levels and the perimysial CD4+ T cell infiltration you see on biopsy.
Answer A correctly describes this coordinated immune response. Answer B incorrectly suggests antibodies are the primary driver and implies regulatory T cell defects are unrelated to HLA presentation. Answer C misunderstands MHC class II function—these molecules present antigens to T cells, not directly activate B cells without T cell help. Answer D dismisses the well-established mechanistic relationship between specific HLA alleles and autoantigen presentation, treating the association as coincidental rather than causal.
Remember: HLA-disease associations aren't just correlations—they reflect specific antigen presentation capabilities. When you see an HLA allele linked to specific autoantibodies, think about which peptides that allele can present and how this drives the autoimmune response.
- During B-cell development, an immature B cell in the bone marrow expresses a B-cell receptor (BCR) that binds with high avidity to a multivalent self-antigen on a stromal cell. Which mechanism of central tolerance is the most definitive fate for this cell if it cannot alter its BCR?
Answer: Clonal deletion through the induction of apoptosis.
When you encounter questions about B-cell central tolerance, focus on the severity of the self-recognition event. The key factors are the strength of binding (avidity), the nature of the antigen (multivalent vs. soluble), and the developmental stage of the B cell.
In this scenario, an immature B cell binds with high avidity to a multivalent self-antigen on a stromal cell. This represents the most dangerous type of self-recognition: strong, crosslinking interactions that would lead to potent autoimmune responses if allowed to persist. When receptor editing fails to resolve this problem, the bone marrow's central tolerance mechanism defaults to the most definitive solution—clonal deletion through apoptosis (Answer D). This permanently eliminates the autoreactive clone before it can mature and enter circulation.
Answer A is incorrect because anergy typically occurs with weaker self-recognition or in peripheral tolerance, not this severe central scenario. Answer B represents clonal ignorance, which happens when self-antigens are present at very low concentrations or are sequestered—not applicable to high-avidity binding with accessible stromal antigens. Answer C describes regulatory B-cell conversion, which isn't a primary central tolerance mechanism for immature B cells and doesn't occur in response to strong self-recognition in the bone marrow.
Remember this pattern: in central tolerance questions, high-avidity binding to multivalent self-antigens almost always leads to deletion when other mechanisms fail. The bone marrow doesn't take chances with strongly autoreactive B cells—it eliminates them completely rather than risking their escape to the periphery.
- A patient with Autoimmune Lymphoproliferative Syndrome (ALPS) is found to have a mutation that inactivates the Fas receptor (CD95). This leads to an accumulation of lymphocytes and splenomegaly because of a failure in which critical process of peripheral tolerance?
Answer: Activation-induced cell death (AICD)
Activation-induced cell death (AICD) is a mechanism for deleting chronically stimulated T cells to maintain immune homeostasis and terminate an immune response. It is primarily mediated by the interaction of the Fas receptor (CD95) on the surface of an activated T cell with its ligand, FasL (CD178), which can be expressed on the same or an adjacent cell. This interaction triggers an apoptotic cascade. In ALPS, mutations in the Fas pathway prevent AICD, leading to the failure to delete activated lymphocytes, including self-reactive ones. This results in the characteristic accumulation of lymphocytes in secondary lymphoid organs.
- An autoreactive T cell that has escaped central tolerance encounters its specific self-antigen on the surface of a resting fibroblast in a peripheral tissue. The fibroblast does not express co-stimulatory molecules like B7. Which outcome is most likely for this T cell following the encounter?
Answer: The T cell will become anergic and functionally unresponsive to subsequent antigen stimulation.
Full T-cell activation requires two signals. Signal 1 is the binding of the T-cell receptor (TCR) to the peptide-MHC complex. Signal 2 is the co-stimulatory signal, typically from the interaction of CD28 on the T cell with B7 molecules (CD80/CD86) on a professional antigen-presenting cell (APC). When a T cell receives Signal 1 in the absence of Signal 2, as in this scenario with a resting parenchymal cell, it enters a state of anergy. Anergic cells are not deleted but are rendered functionally unresponsive to future encounters with their antigen, even if co-stimulation is provided later. This is a key mechanism of peripheral tolerance.
- An individual carrying high-risk HLA alleles for type 1 diabetes remains healthy for decades before a viral infection triggers the rapid onset of autoimmune pancreatic β-cell destruction. This clinical history best illustrates that:
Answer: Loss of self-tolerance is a multifactorial process, often requiring both genetic predisposition and an environmental trigger.
Most autoimmune diseases, including type 1 diabetes, are complex and multifactorial. They do not follow simple Mendelian inheritance. Instead, individuals inherit multiple susceptibility genes (like certain HLA alleles) that create a predisposition but are not sufficient on their own to cause disease. An environmental factor, such as a viral infection, is often required to break tolerance and initiate the autoimmune process in a genetically susceptible host. This 'two-hit' model, involving both genetics and environment, is a central concept in the pathogenesis of autoimmunity.
- A patient develops an autoimmune disorder characterized by the presence of T cells reactive to a wide range of tissue-specific antigens. Genetic analysis reveals a loss-of-function mutation in the AIRE gene. This mutation most directly impairs which of the following immunologic processes?
Answer: The expression of tissue-specific antigens in the thymus, leading to failed negative selection.
The Autoimmune Regulator (AIRE) protein is a transcription factor critical for central tolerance. It drives the expression of a wide array of tissue-specific antigens (TSAs) by medullary thymic epithelial cells (mTECs). This expression allows for the presentation of self-peptides to developing T cells (thymocytes). T cells that bind these self-peptides with high affinity are eliminated through negative selection. A loss-of-function mutation in AIRE prevents the expression of TSAs in the thymus, allowing T cells reactive to these antigens to escape deletion, mature, and enter the periphery, leading to widespread autoimmunity (as seen in APECED syndrome).
- A strong genetic association exists between the HLA-DR4 allele and the risk of developing rheumatoid arthritis. What is the most direct pathophysiological role of the HLA-DR4 protein in this disease?
Answer: It preferentially presents specific arthritogenic self-peptides to autoreactive CD4+ T cells.
Human Leukocyte Antigen (HLA) molecules are MHC molecules. HLA-DR4 is a specific allele of the MHC class II gene. The primary function of MHC class II molecules is to present extracellularly-derived peptides to CD4+ T helper cells. In rheumatoid arthritis, it is believed that the peptide-binding groove of the HLA-DR4 molecule is particularly effective at binding and presenting certain self-peptides (e.g., from citrullinated proteins) found in the joint. This presentation leads to the activation of autoreactive CD4+ T cells, which orchestrate the chronic inflammatory response in the synovium.
- Skin biopsies from a patient with severe psoriasis show dense neutrophilic infiltrates and hyperproliferating keratinocytes. The inflammatory milieu is rich in IL-17 and IL-22. This cytokine profile points to the pathogenic activity of which T helper cell subset?
Answer: Th17 cells
Th17 cells are a subset of CD4+ T helper cells characterized by their production of the signature cytokine IL-17, as well as IL-22. IL-17 is a potent pro-inflammatory cytokine that is particularly effective at recruiting neutrophils to sites of inflammation. IL-22 acts on epithelial cells, such as keratinocytes in the skin, promoting their proliferation and production of antimicrobial peptides. This combination of effects is central to the pathophysiology of psoriasis and other autoimmune diseases like rheumatoid arthritis and multiple sclerosis.
- A patient with metastatic melanoma is treated with ipilimumab, an antibody that blocks CTLA-4. While the cancer responds, the patient develops severe autoimmune hypophysitis. By blocking CTLA-4, this therapy disrupts a key mechanism of self-tolerance. What is the direct function of CTLA-4 that is inhibited?
Answer: It competes with CD28 for B7 binding, delivering an inhibitory signal to the T cell.
CTLA-4 (Cytotoxic T-Lymphocyte-Associated protein 4) is an inhibitory receptor expressed on activated T cells and regulatory T cells. It has a higher affinity for B7 molecules (CD80/CD86) on antigen-presenting cells than the co-stimulatory receptor CD28. When CTLA-4 binds to B7, it delivers an inhibitory signal, effectively acting as a 'brake' on T-cell activation. By blocking CTLA-4, ipilimumab removes this brake, leading to sustained T-cell activation. This enhances the anti-tumor response but can also unleash autoreactive T cells, causing immune-related adverse events like hypophysitis.
- A patient with pemphigus vulgaris initially has autoantibodies only against desmoglein-3. As the disease progresses over several years, their serum is found to also contain high-titer autoantibodies against desmoglein-1. This diversification of the autoimmune response is best explained by:
Answer: Epitope spreading
Epitope spreading is the phenomenon where an initial immune response against one epitope of a self-antigen (or a single protein) leads to the development of immune responses against other epitopes on the same protein or different proteins in the same tissue. The initial tissue damage caused by the anti-desmoglein-3 response releases and exposes other self-antigens, such as desmoglein-1, in an inflammatory context. This leads to the activation of new B and T cell clones specific for these secondary antigens, resulting in a broadened and often more severe autoimmune response.
- A patient with a genetic predisposition to multiple sclerosis develops a CNS viral infection. The resulting inflammation leads to the activation of pre-existing, dormant T cells specific for myelin basic protein (MBP), even though no viral proteins are structurally similar to MBP. This activation of self-reactive T cells due to local inflammation is termed:
Answer: Bystander activation
Bystander activation occurs when a localized infection or tissue damage creates a highly inflammatory microenvironment. The release of cytokines and danger signals causes local antigen-presenting cells (APCs) to become activated and upregulate co-stimulatory molecules (like B7). These activated APCs may take up and present local self-antigens (like MBP). Pre-existing autoreactive T cells that encounter their specific self-antigen on these fully activated APCs will receive the necessary signals for their own activation, thus initiating an autoimmune attack, despite the initial trigger being unrelated antigenically.
- A patient with systemic lupus erythematosus (SLE) has a homozygous deficiency of the C1q complement component. This deficiency most critically impairs which process, thereby contributing to the loss of self-tolerance?
Answer: The efficient clearance of apoptotic bodies and immune complexes by phagocytes.
When you encounter complement deficiency questions in pathophysiology, focus on which specific complement component is affected and trace its primary biological role. C1q is the initiating component of the classical complement pathway, and its deficiency creates a specific pathological cascade.
C1q's most critical function is opsonizing apoptotic cells and immune complexes, marking them for phagocytic clearance. Without functional C1q, these cellular debris and antigen-antibody complexes accumulate in tissues. This accumulation is catastrophic because apoptotic cells contain nuclear antigens (DNA, histones, ribonucleoproteins) that, when not promptly cleared, become immunogenic. The immune system then recognizes these self-antigens as foreign, breaking self-tolerance and triggering autoantibody production—the hallmark of SLE. This explains why C1q deficiency is one of the strongest genetic risk factors for lupus.
Choice A is incorrect because the membrane attack complex (C5b-9) forms through the terminal complement pathway, which doesn't require C1q. Choice B is wrong because anaphylatoxins C3a and C5a are generated through alternative and lectin pathways that bypass C1q. Choice C misrepresents complement's role—while complement can influence B-cell responses, C1q deficiency doesn't primarily impair B-cell co-receptor activation.
The correct answer is D because impaired clearance of apoptotic material directly leads to autoantigen exposure and loss of self-tolerance.
Study tip: For complement deficiency questions, map each component to its primary function. Early complement deficiencies (C1q, C2, C4) typically cause autoimmunity through poor clearance, while late deficiencies (C5-C9) cause recurrent infections due to impaired bacterial killing.
- A young boy presents with severe, recurrent infections, eczema, and multi-organ autoimmunity, consistent with IPEX syndrome. A mutation in the FOXP3 gene is identified. The failure of which specific cell population is the primary cause of the widespread loss of self-tolerance in this patient?
Answer: Regulatory T (Treg) cells, causing a profound defect in peripheral immune suppression.
The FOXP3 gene encodes a master transcription factor that is essential for the development, maintenance, and function of regulatory T (Treg) cells. Tregs are a critical component of peripheral tolerance, actively suppressing the activation and proliferation of self-reactive T cells that have escaped central tolerance. A loss-of-function mutation in FOXP3, as seen in IPEX (Immune dysregulation, Polyendocrinopathy, Enteropathy, X-linked) syndrome, leads to a near-complete absence of functional Tregs, resulting in catastrophic, systemic autoimmunity.
